← back to dashboard

STLN

Starling Oncology, Inc.
Composite
0.05
EDGAR
0.05
Filings (90d)
2
Peak
0.03
Last Signal
2026-08-21T17:25

All Filings

Filed Form Items Signal Score Summary Link
2026-08-21 17:25 8-K ["1.01", "2.03"] material agreement 0.05 Revolving credit facility with healthcare lender; standard financing arrangement unrelated to M&A. SEC · detail
2026-08-06 16:32 8-K ["2.02", "9.01"] other 0.05 Routine earnings announcement with no M&A signals or strategic transaction indicators. SEC · detail